Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 7/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.59 |
| ▸ | MAPT | P10636 | 9/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.58 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13538746 | 0.93 | NR1H4 (0.58) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL3032465 | 0.86 | NR1H4 (0.62) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL11100803 | 0.85 | NR1H4 (0.72) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL12869943 | 0.84 | NR1H4 (0.70) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL2921932 | 0.82 | NR1H4 (0.64) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL1068265 | 0.82 | MEN1 (0.85) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL11330304 | 0.81 | NR1H4 (0.67) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL6718058 | 0.80 | NR1H4 (0.65) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL1147726 | 0.80 | NR1H4 (0.61) | NR1H4MEN1KMT2AMAPTLMNA | |
| SCHEMBL438314 | 0.79 | MEN1 (0.70) | NR1H4MEN1KMT2AMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765967-B2 | Microcapsules with UV filter activity and process for producing them | DSM IP ASSETS B.V. (NE) | 2014-07-01 | — | — | US | disclosed |
| US-8765967-B2 | Microcapsules with UV filter activity and process for producing them | DSM IP ASSETS B.V. (NE) | 2014-07-01 | — | — | US | disclosed |
| EP-1885769-B1 | NOVEL POLYSILOXANE SUNSCREENS | DSM IP ASSETS BV (NL) | 2013-08-28 | — | — | EP | disclosed |
| EP-1885769-B1 | NOVEL POLYSILOXANE SUNSCREENS | DSM IP ASSETS BV (NL) | 2013-08-28 | — | — | EP | disclosed |
| EP-1722863-B1 | MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM | DSM IP ASSETS BV (NL) | 2012-02-08 | — | — | EP | disclosed |
| EP-2192142-B1 | Novel process | DSM IP ASSETS BV (NL) | 2012-02-08 | — | — | EP | disclosed |
| US-8110647-B2 | Process for the preparation of an organopolysiloxane functionalized with a benzalmalonate by hydrosilylation in the presence of a hydroxy carboxylic acid or a cyclic ester thereof | DSM IP ASSETS B.V. (NL) | 2012-02-07 | — | — | US | disclosed |
| US-20120022265-A1 | MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM | BERG-SCHULTZ KATJA (CH) | 2012-01-26 | — | — | US | disclosed |
| US-20120022265-A1 | MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM | BERG-SCHULTZ KATJA (CH) | 2012-01-26 | — | — | US | disclosed |
| US-7906108-B2 | Polysiloxane sunscreens | DSM IP ASSETS B.V. (NL) | 2011-03-15 | — | — | US | disclosed |
| US-20090068127-A1 | Novel Polysiloxane Sunscreens | DSM IP ASSETS B.V. (NL) | 2009-03-12 | — | — | US | disclosed |
| US-20090068127-A1 | Novel Polysiloxane Sunscreens | DSM IP ASSETS B.V. (NL) | 2009-03-12 | — | — | US | disclosed |
| EP-1885769-A1 | NOVEL POLYSILOXANE SUNSCREENS | DSMIP Assets B.V. (NL) | 2008-02-13 | — | — | EP | disclosed |
| US-20070190325-A1 | Microcapsules with uv filter activity and process for producing them | DSM IP ASSETS B.V. (NL) | 2007-08-16 | — | — | US | disclosed |
| US-20070190325-A1 | Microcapsules with uv filter activity and process for producing them | DSM IP ASSETS B.V. (NL) | 2007-08-16 | — | — | US | disclosed |
| WO-2006128614-A1 | NOVEL POLYSILOXANE SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2006-12-07 | — | — | WO | disclosed |
| US-20060160976-A1 | Sunscreens | DSM IP ASSETS B.V. (NL) | 2006-07-20 | — | — | US | disclosed |
| EP-1521798-A1 | SUNSCREENS | DSM IP Assets B.V. (NL) | 2005-04-13 | — | — | EP | disclosed |
| WO-2004007592-A1 | SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2004-01-22 | — | — | WO | disclosed |
| US-6114559-A | Silicone-substituted cinnamamide/malonamide/malonate compounds and photoprotective compositions comprised thereof | SOCIETE L'OREAL S.A. (FR) | 2000-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068127-A1 | Novel Polysiloxane Sunscreens | ERCC4, ERCC1, RAD54L | NR1H4 4235/4885MEN1 3065/4885KMT2A 1479/4885 |
| US-20120022265-A1 | MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM | UACA, UROD, UMPS | NR1H4 4464/4885MEN1 1079/4885KMT2A 4368/4885 |
| US-20070190325-A1 | Microcapsules with uv filter activity and process for producing them | UACA, UROD, UMPS | NR1H4 4464/4885MEN1 1079/4885KMT2A 4368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.